DCM
SRPT icon

Dupont Capital Management’s Sarepta Therapeutics SRPT Stock Holding History

Dupont Capital Management’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,319
Closed -$151K – 517
2023
Q2 		$151K Buy
1,319
+821
+165% +$106K 0.01% 412
2023
Q1 		$68.6K Sell
498
-3,047
-86% -$395K ﹤0.01% 517
2022
Q4 		$459K Sell
3,545
-4,009
-53% -$465K 0.02% 588
2022
Q3 		$835K Buy
7,554
+3,114
+70% +$314K 0.05% 463
2022
Q2 		$333K Buy
+4,440
New +$327K 0.02% 839
2020
Q1 		– Sell
-4,169
Closed -$538K – 1370
2019
Q4 		$538K Hold
4,169
– – 0.01% 811
2019
Q3 		$314K Sell
4,169
-990
-19% -$117K 0.01% 976
2019
Q2 		$784K Sell
5,159
-2,082
-29% -$253K 0.02% 616
2019
Q1 		$863K Buy
7,241
+1,977
+38% +$254K 0.02% 589
2018
Q4 		$574K Hold
5,264
– – 0.01% 687
2018
Q3 		$850K Buy
5,264
+1,437
+38% +$196K 0.02% 604
2018
Q2 		$506K Sell
3,827
-1,836
-32% -$173K 0.01% 704
2018
Q1 		$420K Sell
5,663
-15,706
-73% -$1.05M 0.01% 703
2017
Q4 		$1.19M Buy
21,369
+8,647
+68% +$458K 0.03% 481
2017
Q3 		$577K Buy
12,722
+3,069
+32% +$123K 0.01% 642
2017
Q2 		$325K Hold
9,653
– – 0.01% 760
2017
Q1 		$286K Sell
9,653
-6,995
-42% -$216K 0.01% 789
2016
Q4 		$457K Buy
+16,648
New +$669K 0.01% 716
2014
Q4 		– Sell
-14,415
Closed -$304K – 642
2014
Q3 		$304K Buy
14,415
+2,380
+20% +$53.7K 0.01% 604
2014
Q2 		$359K Buy
+12,035
New +$380K 0.01% 603

Other funds holding SRPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Dupont Capital Management's SRPT Position: Q3 2023 in Review

Dupont Capital Management sold out of Sarepta Therapeutics (SRPT) in Q3 2023, closing a stake of 1,319 shares — an estimated $151K sold.

Dupont Capital Management first reported a position in SRPT in Q2 2014 and held it in 20 quarters. The position peaked at $1.19M in Q4 2017. 394 funds tracked by Wall St. Rank hold SRPT as of Q3 2023.

  • Dupont Capital Management reported no remaining Sarepta Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Dupont Capital Management sold 1,319 Sarepta Therapeutics shares in Q3 2023, an estimated $151K.
  • Dupont Capital Management first reported a position in Sarepta Therapeutics in Q2 2014 and held it in 20 quarters.
  • Dupont Capital Management's Sarepta Therapeutics position peaked at $1.19M in Q4 2017.
  • 394 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2023.

Based on Dupont Capital Management's 13F filing for Q3 2023, filed 27 Oct 2023.